Lenalidomide Sandoz 10 Mg Hard Capsules (Lenalidomide)

Lenalidomide binds to cereblon, a component of the CRL4‑E3 ubiquitin ligase complex, changing its substrate specificity. This leads to the degradation of transcription factors Ikaros and Aiolos, which modulates cytokine release, inhibits new blood‑vessel formation, and exerts direct anti‑tumor effects on malignant hematologic cells.

The dosing regimen for Lenalidomide Sandoz 10 mg is determined by the prescribing physician based on the specific indication, disease stage, patient characteristics, and concomitant therapies. Patients should follow the exact dose and schedule provided by their healthcare professional.

Lenalidomide is classified with an unknown pregnancy category, and it is generally contraindicated during pregnancy because of potential fetal harm. Women of child‑bearing potential should use effective contraception, and breastfeeding is not recommended while taking the medication.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required cold‑chain) and import documentation.

The primary alternative to lenalidomide within the IMiD class is thalidomide, while pomalidomide is a newer analogue. Lenalidomide generally offers a more favorable safety profile than thalidomide, with lower rates of peripheral neuropathy, and it provides stronger anti‑angiogenic and immunomodulatory activity compared with earlier agents.

Store Lenalidomide capsules at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect from moisture and direct light, and ensure the cap is tightly closed to maintain product stability.

Lenalidomide is taken orally. Patients should swallow each hard capsule whole with water, preferably on an empty stomach unless otherwise directed by their clinician. The medication can be taken with or without food, but consistency with regard to meals helps maintain stable absorption.

Key serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe neutropenia that can predispose to infections, hepatotoxicity indicated by elevated liver enzymes, and the potential development of secondary malignancies. Prompt medical attention is required if any of these occur.

Lenalidomide should not be used by pregnant women, individuals with known hypersensitivity to the drug or its excipients, and patients with severe renal impairment unless a specialist determines a safe approach. Caution is also advised for those with uncontrolled infections or significant liver disease.